Sea Pharmaceuticals, LLC

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Biomodels in Waltham offers a wide range of preclinical research services, specializing in contract services for biopharmaceutical companies. Their experienced team provides comprehensive preclinical CRO services to support the development of innovative therapies and drug candidates. Generated from their website's infomation

MBL International Corporation is a trusted global resource for scientists in need of life science research products, offering a wide range of antibodies, cell culture kits, MHC tetramers, and more. With a focus on high specificity immune monitoring, MBL International provides MHC tetramers and monomers for precise analysis of immune responses. Additionally, MBL International offers the QuickSwitch system, allowing researchers to create their own functional and ready-to-use MHC tetramers in-house. Committed to advancing unique research needs, MBL International is dedicated to helping scientists make groundbreaking discoveries in various research areas, including immunology, cancer, drug discovery, and neuroscience.Generated from the website